數位療法市場規模、佔有率和成長分析（按交付類型、應用、收入模式、銷售管道和地區分類）—2026-2033年行業預測

全球數位療法市場規模預計在 2024 年達到 40.1 億美元，從 2025 年的 46.8 億美元成長到 2033 年的 159.9 億美元，在預測期（2026-2033 年）內複合年成長率為 16.61%。

全球數位療法市場正迅速發展，整合先進技術、服務和產品，以提升醫療保健和健康促進水平。這些解決方案利用行動應用、機器學習、巨量資料和人工智慧，為心血管疾病、癌症和糖尿病等慢性病提供個人化治療方案。智慧型手機在全球的普及，尤其是在開發中國家，正在推動對數位健康解決方案的需求，並帶來巨大的成長機會。遠端醫療現代醫療保健策略的關鍵組成部分，強調醫療服務的安全性、品質和以患者為中心的理念。

全球數位療法市場按交付方式、應用領域、收入模式、銷售管道和地區進行細分。依交付方式分類，可分為軟體/平台、程式和虛擬實境/遊戲。依應用領域分類，可分為治療/護理相關應用與預防應用。依收入模式分類，可分為訂閱模式、一次性購買/年度授權模式和基於結果/價值的模式。依銷售管道，可分為B2B銷售管道及B2C銷售管道。按地區分類，可分為北美、歐洲、亞太、中東和非洲以及拉丁美洲。

全球數位療法市場促進因素

全球數位療法市場正經歷顯著成長，這主要得益於對用於管理和治療慢性疾病的治療軟體和設備的需求不斷成長。包括糖尿病、多種癌症、阿茲海默症、肥胖症和胃腸道疾病在內的各種慢性疾病的盛行率正在上升。這一趨勢在新興經濟體尤為明顯，從而推動了對創新數位解決方案的需求。隨著醫療服務提供者和患者尋求有效的管理工具，數位療法的應用日益普及，這反映出人們越來越認知到數位療法在改善不同患者群體健康方面的潛力。

全球數位療法市場面臨的限制因素

全球數位療法市場以創新軟體和設備驅動的解決方案為特徵，旨在預防、管理和治療各種疾病。然而，諸多限制阻礙了其發展。其中一個關鍵因素是日益嚴重的網路安全問題，這引發了人們對患者資料安全的嚴重擔憂，並阻礙了數位療法的廣泛應用。此外，監管政策不明朗、報銷難題以及技術取得方面的差異也進一步阻礙了市場擴張。隨著患者對自身醫療資訊潛在風險的認知不斷提高，這些因素也使得數位療法解決方案在醫療機構中的應用變得更加複雜。

全球數位療法市場趨勢

全球數位療法市場的一個顯著趨勢是人工智慧 (AI) 和機器學習技術的日益融合，以實現個人化治療並提升病人參與。這些先進技術能夠開發出更有效、更具適應性的治療方法，以滿足個別患者的需求並利用即時健康數據。此外，隨著人們對心理健康和慢性病管理的認知不斷提高，醫療服務提供者和患者的接受度也日益增強，這進一步推動了市場成長。這一趨勢凸顯了遠距遠端醫療。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 專利分析
• 技術分析
• 案例研究

全球數位療法市場規模（按產品類型和複合年成長率分類）（2026-2033 年）

• 軟體/平台
• 程式
• 虛擬實境/遊戲

全球數位療法市場規模（按應用領域及複合年成長率分類）（2026-2033 年）

• 治療和護理應用
  • 糖尿病
  • 中樞神經系統（CNS）疾病
  • 精神疾病
  • 其他中樞神經系統疾病
  • 禁止抽煙
  • 慢性呼吸系統疾病
  • 肌肉骨骼疾病
  • 心血管疾病
  • 用藥依從性
  • 消化系統疾病
  • 復健和患者照護
  • 物質使用疾患與成癮管理
  • 其他治療和護理應用
• 預防性應用
  • 糖尿病前期
  • 肥胖
  • 營養
  • 生活方式管理
  • 其他預防性應用

全球數位療法市場規模（按收入模式和複合年成長率分類）（2026-2033 年）

• 訂閱模式
• 一次性購買/年度授權模式
• 結果/價值導向模型

全球數位療法市場規模（按銷售管道和複合年成長率分類）（2026-2033 年）

• B2B銷售管道
  • 付款人
  • 雇主
  • 製藥公司
  • 醫療保健提供者
  • 其他買家
• B2C銷售管道
  • 看護者
  • 病人

全球數位療法市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Noom, Inc
• Teladoc Health, Inc.
• Omada Health, Inc.
• WellDoc, Inc
• Biofourmis
• Better Therapeutics, Inc
• Amalgm Rx
• CogniFit Inc
• Headspace Health
• Propeller Health
• Virta Health Corp
• 2Morrow, Inc.
• Realizedcare（via XRHealth）
• Canary Health
• Twill Inc.
• Click Therapeutics, Inc.
• Akili, Inc.
• Cognoa, Inc
• Wellthy Therapeutics Pvt. Ltd.
• Kaia Health

結論與建議

Global Digital Therapeutics Market size was valued at USD 4.01 Billion in 2024 and is poised to grow from USD 4.68 Billion in 2025 to USD 15.99 Billion by 2033, growing at a CAGR of 16.61% during the forecast period (2026-2033).

The global digital therapeutics market is rapidly evolving, integrating advanced technologies, services, and products to enhance healthcare and wellness. Leveraging mobile apps, machine learning, big data, and artificial intelligence, these solutions provide personalized treatment regimens, targeting chronic diseases such as cardiovascular conditions, cancer, and diabetes. As smartphone adoption rises globally, particularly in developing nations, the demand for digital health solutions is increasing, presenting significant growth opportunities. Notably, telemedicine is gaining traction in low-income areas, connecting patients to necessary healthcare resources while reducing infrastructure costs. With a growing elderly population and a rising burden of chronic diseases, digital therapeutics is positioned as a crucial element in contemporary healthcare strategies, emphasizing safety, quality, and patient-centered principles in treatment delivery.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Therapeutics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital Therapeutics Market Segments Analysis

Global digital therapeutics market is segmented on the basis of Offering, Application, Revenue Model, Sales Channel, and region. By Offering, the market is segmented into Software/Platforms, Programs, and Virtual Reality/Games. By Application, the market is segmented into Treatment/Care-Related Applications. Preventive Applications. By Revenue Model, the market is segmented into Subscription-Based Model, One-Time Purchase/Annual Licensing Model, Outcome /Value-Based Model. By Sales Channel, the market is segmented into B2B Sales Channel and B2C Sales Channels. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Global Digital Therapeutics Market

The Global Digital Therapeutics market is experiencing significant growth driven by the rising demand for therapeutic software and devices aimed at managing and treating chronic diseases worldwide. The prevalence of chronic conditions, including various forms of diabetes, cancers, Alzheimer's disease, obesity, and gastrointestinal disorders, is on the rise. This trend is particularly pronounced in emerging economies, where there is heightened demand for innovative digital solutions. As healthcare providers and patients increasingly seek effective management tools, the adoption of digital therapeutics is expanding, reflecting a growing recognition of their potential to enhance health outcomes in diverse patient populations.

Restraints in the Global Digital Therapeutics Market

The Global Digital Therapeutics market is characterized by innovative software and device-driven solutions designed to prevent, manage, or treat various medical conditions. However, several constraints are hindering its growth. Chief among these are escalating cybersecurity issues, which raise significant concerns regarding the safety of patient data and limit the widespread acceptance of digital therapeutics. Additionally, a lack of regulatory clarity coupled with challenges related to reimbursement and unequal access to technology further obstructs market expansion. As patients become increasingly aware of potential risks associated with their medical information, these factors complicate the adoption of digital therapeutic solutions in healthcare settings.

Market Trends of the Global Digital Therapeutics Market

A significant trend in the global digital therapeutics market is the increasing integration of artificial intelligence and machine learning technologies to enhance treatment personalization and patient engagement. These advanced capabilities allow for the development of more effective, adaptive therapies that cater to individual patient needs and real-time health data. Additionally, growing acceptance among healthcare providers and patients, driven by rising awareness of mental health and chronic disease management, further fuels market expansion. This trend underscores the ongoing shift toward remote care solutions, improving accessibility, and bridging the gap between traditional healthcare delivery and innovative digital health interventions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Patent Analysis
• Technology Analysis
• Case Studies

Global Digital Therapeutics Market Size by Offering & CAGR (2026-2033)

• Market Overview
• Software/Platforms
• Programs
• Virtual Reality/Games

Global Digital Therapeutics Market Size by Application & CAGR (2026-2033)

• Market Overview
• Treatment/Care-Related Applications
  • Diabetes
  • Central Nervous System (CNS) Disorders
  • Mental health disorders
  • Other CNS disorders
  • Smoking Cessation
  • Chronic Respiratory Diseases
  • Musculoskeletal Disorders
  • Cardiovascular Diseases
  • Medication Adherence
  • Gastrointestinal Disorders
  • Rehabilitation & Patient Care
  • Substance Use Disorders & Addiction Management
  • Other Treatment/Care-Related Applications
• Preventive Applications
  • Prediabetes
  • Obesity
  • Nutrition
  • Lifestyle Management
  • Other Preventive Applications

Global Digital Therapeutics Market Size by Revenue Model & CAGR (2026-2033)

• Market Overview
• Subscription-Based Model
• One-Time Purchase/Annual Licensing Model
• Outcome /Value-Based Model

Global Digital Therapeutics Market Size by Sales Channel & CAGR (2026-2033)

• Market Overview
• B2B Sales Channel
  • Payers
  • Employers
  • Pharmaceutical Companies
  • Providers
  • Other Buyers
• B2C Sales Channel
  • Caregivers
  • Patients

Global Digital Therapeutics Market Size & CAGR (2026-2033)

• North America (Offering, Application, Revenue Model, Sales Channel)
  • US
  • Canada
• Europe (Offering, Application, Revenue Model, Sales Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Offering, Application, Revenue Model, Sales Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Offering, Application, Revenue Model, Sales Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Offering, Application, Revenue Model, Sales Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Noom, Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teladoc Health, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omada Health, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WellDoc, Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biofourmis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Better Therapeutics, Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amalgm Rx
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CogniFit Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Headspace Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Propeller Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virta Health Corp
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 2Morrow, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Realizedcare (via XRHealth)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canary Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twill Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Click Therapeutics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akili, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cognoa, Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wellthy Therapeutics Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kaia Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations